Trials / Completed
CompletedNCT00562458
Non-interventional Study to Evaluate Arimidex in Postmenopausal Women With Advanced Breast Cancer
ARIMIDEX Study ( Non-interventional Study to Evaluate Arimidex in Adjuvant Therapy in Partial or Complete Response or Stabilized Disease After First Line Chemotherapy in Postmenopausal Women With Advanced Breast Cancer)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 200 (actual)
- Sponsor
- AstraZeneca · Industry
- Sex
- Female
- Age
- —
- Healthy volunteers
- Not accepted
Summary
To evaluate Arimidex 6 month therapy as an adjuvant treatment in postmenopausal patients with advanced breast cancer in whom a partial or complete response or stabilized disease were obtained with first line chemotherapy, by tumoral response assessment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | anastrozole |
Timeline
- Start date
- 2006-12-01
- First posted
- 2007-11-22
- Last updated
- 2013-02-05
Source: ClinicalTrials.gov record NCT00562458. Inclusion in this directory is not an endorsement.